NasdaqCM - Nasdaq Real Time Price USD
Processa Pharmaceuticals, Inc. (PCSA)
0.2538
+0.0119
+(4.92%)
At close: May 20 at 4:00:00 PM EDT
0.2460
-0.01
(-3.07%)
Pre-Market: 7:52:21 AM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 1 | 1 | 1 | -- |
| Avg. Estimate | -0.65 | -0.48 | -2.16 | 0 |
| Low Estimate | -0.65 | -0.48 | -2.16 | 0 |
| High Estimate | -0.65 | -0.48 | -2.16 | 0 |
| Year Ago EPS | -1.01 | -1.03 | -3.87 | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 1 | 1 | 2 | 1 |
| Avg. Estimate | -- | -- | -- | -- |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | -- | -- |
| Year Ago Sales | -- | -- | -- | -- |
| Sales Growth (year/est) | 0.00% | 0.00% | 0.00% | 0.00% |
Earnings History
| Currency in USD | 6/30/2024 | 9/30/2024 | 12/31/2024 | 3/31/2025 |
|---|---|---|---|---|
| EPS Est. | -0.98 | -1 | -0.92 | -0.77 |
| EPS Actual | -1.01 | -1.03 | -0.74 | -0.3 |
| Difference | -0.03 | -0.03 | 0.18 | 0.47 |
| Surprise % | -3.06% | -3.00% | 19.57% | 61.04% |
EPS Trend
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -0.65 | -0.48 | -2.16 | 0 |
| 7 Days Ago | -0.55 | -0.47 | -2.16 | 0 |
| 30 Days Ago | -0.55 | -0.47 | -2.16 | 0 |
| 60 Days Ago | -0.55 | -0.47 | -2.16 | 0 |
| 90 Days Ago | -0.55 | -0.47 | -2.16 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | 1 | -- |
| Down Last 30 Days | -- | -- | 1 | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| PCSA | 35.64% | 53.40% | 44.19% | -- |
| S&P 500 | 13.32% | 2.69% | 7.77% | 13.75% |
Upgrades & Downgrades
| Reiterates | HC Wainwright & Co.: Buy to Buy | 12/5/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 8/20/2024 |
| Maintains | HC Wainwright & Co.: Buy to Buy | 8/19/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 8/1/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 6/12/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 5/13/2024 |
Related Tickers
TNFA TNF Pharmaceuticals, Inc.
0.1791
-10.14%
VOR Vor Biopharma Inc.
0.1785
+1.71%
ONCO Onconetix, Inc.
0.0880
+8.37%
LYRA Lyra Therapeutics, Inc.
0.0964
-9.82%
PBM Psyence Biomedical Ltd.
5.32
-11.48%
ASBP Aspire Biopharma Holdings, Inc.
0.2403
-3.92%
NLSP NLS Pharmaceutics AG
1.7300
+2.37%
ALLR Allarity Therapeutics, Inc.
1.1000
+2.80%
ZVSA ZyVersa Therapeutics, Inc.
0.5396
+1.97%
ABP Abpro Corporation
0.2549
-6.29%